Merle L. Diamond

7.3k total citations · 3 hit papers
52 papers, 5.6k citations indexed

About

Merle L. Diamond is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Merle L. Diamond has authored 52 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Psychiatry and Mental health, 32 papers in Pathology and Forensic Medicine and 19 papers in Physiology. Recurrent topics in Merle L. Diamond's work include Migraine and Headache Studies (49 papers), Trigeminal Neuralgia and Treatments (23 papers) and Sympathectomy and Hyperhidrosis Treatments (19 papers). Merle L. Diamond is often cited by papers focused on Migraine and Headache Studies (49 papers), Trigeminal Neuralgia and Treatments (23 papers) and Sympathectomy and Hyperhidrosis Treatments (19 papers). Merle L. Diamond collaborates with scholars based in United States, Germany and Denmark. Merle L. Diamond's co-authors include Richard B. Lipton, Michael L. Reed, Walter F. Stewart, Seymour Diamond, Frederick G. Freitag, Marcelo E. Bigal, Roger Cady, George Papadopoulos, Anthony W. Fox and Egilius L.H. Spierings and has published in prestigious journals such as JAMA, Neurology and Obstetrics and Gynecology.

In The Last Decade

Merle L. Diamond

50 papers receiving 5.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II

2001 1.8k citations Richard B. Lipton, Walter F. Stewart et al. Headache The Journal of Head and Face Pain profile →
Migraine prevalence, disease burden, and the need for preventive therapy

2007 1.8k citations Richard B. Lipton, Merle L. Diamond et al. Neurology profile →
Migraine Diagnosis and Treatment: Results From the American Migraine Study II

2001 573 citations Richard B. Lipton, Seymour Diamond et al. Headache The Journal of Head and Face Pain profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Merle L. Diamond United States	27	5.1k	3.1k	1.9k	561	400	52	5.6k
Jan Lewis Brandes United States	36	4.4k 0.9×	2.8k 0.9×	1.8k 1.0×	473 0.8×	282 0.7×	73	5.0k
Alan M. Rapoport United States	41	5.6k 1.1×	3.4k 1.1×	2.5k 1.4×	539 1.0×	509 1.3×	200	6.5k
Andrew Dowson United Kingdom	31	4.2k 0.8×	2.2k 0.7×	1.3k 0.7×	538 1.0×	393 1.0×	90	5.3k
Mattias Linde Norway	47	5.9k 1.2×	2.9k 0.9×	1.8k 1.0×	590 1.1×	418 1.0×	125	6.9k
RB Lipton United States	29	4.3k 0.8×	2.7k 0.9×	1.8k 1.0×	481 0.9×	248 0.6×	41	4.7k
E. Anne MacGregor United Kingdom	39	4.1k 0.8×	2.3k 0.7×	1.4k 0.8×	299 0.5×	369 0.9×	150	5.1k
Seymour Diamond United States	29	4.5k 0.9×	2.6k 0.8×	1.8k 1.0×	568 1.0×	401 1.0×	160	5.4k
Kristina M. Fanning United States	39	4.1k 0.8×	2.0k 0.7×	1.1k 0.6×	441 0.8×	290 0.7×	88	4.8k
Paul Winner United States	35	4.2k 0.8×	2.3k 0.7×	1.9k 1.0×	1.1k 1.9×	275 0.7×	111	4.8k
Joel R. Saper United States	42	5.4k 1.1×	3.4k 1.1×	2.8k 1.5×	649 1.2×	312 0.8×	119	6.5k

Countries citing papers authored by Merle L. Diamond

Since Specialization

Citations

This map shows the geographic impact of Merle L. Diamond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Merle L. Diamond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Merle L. Diamond more than expected).

Fields of papers citing papers by Merle L. Diamond

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Merle L. Diamond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Merle L. Diamond. The network helps show where Merle L. Diamond may publish in the future.

Co-authorship network of co-authors of Merle L. Diamond

This figure shows the co-authorship network connecting the top 25 collaborators of Merle L. Diamond. A scholar is included among the top collaborators of Merle L. Diamond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Merle L. Diamond. Merle L. Diamond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Diamond, Merle L., et al.. (2025). Sudden cardiac death in an adolescent with unusual coronary artery anomaly. Cardiology in the Young. 35(5). 1051–1053.

Tepper, Stewart J., et al.. (2024). Eptinezumab treatment was associated with longer interictal headache/migraine periods which corresponded to greater improvements in patient-reported quality of life measures. Journal of Neurology. 272(1). 4–4. 1 indexed citations

Klein, Brad, Rosa Miceli, Lawrence Severt, et al.. (2022). Evaluation of the Long-Term Safety and Tolerability of Oral Atogepant 60 Mg Once Daily for Preventive Treatment of Migraine: A Phase 3, 40-Week, Multicenter Extension to the Advance Trial (P3-2.001). Neurology. 98(18_supplement).

Silberstein, Stephen D., Merle L. Diamond, Nada Hindiyeh, et al.. (2020). Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study. The Journal of Headache and Pain. 21(1). 120–120. 72 indexed citations

Diamond, Merle L., et al.. (2014). Diagnosing and Understanding Adult Headache. Otolaryngologic Clinics of North America. 47(2). 175–185. 6 indexed citations

Cady, Roger, Merle L. Diamond, Michael P. Diamond, et al.. (2011). Sumatriptan–Naproxen Sodium for Menstrual Migraine and Dysmenorrhea: Satisfaction, Productivity, and Functional Disability Outcomes. Headache The Journal of Head and Face Pain. 51(5). 664–673. 24 indexed citations

Diamond, Merle L., Roger Cady, Lian Mao, et al.. (2008). Characteristics of Migraine Attacks and Responses to Almotriptan Treatment: A Comparison of Menstrually Related and Nonmenstrually Related Migraines. Headache The Journal of Head and Face Pain. 48(2). 248–258. 50 indexed citations

Freitag, Fred, Merle L. Diamond, Seymour Diamond, et al.. (2008). Efficacy and Tolerability of Coadministration of Rizatriptan and Acetaminophen vs Rizatriptan or Acetaminophen Alone for Acute Migraine Treatment. Headache The Journal of Head and Face Pain. 48(6). 921–930. 23 indexed citations

Friedman, Benjamin W., Daniel Serrano, Michael L. Reed, Merle L. Diamond, & Richard B. Lipton. (2008). Use of the Emergency Department for Severe Headache. A Population‐Based Study. Headache The Journal of Head and Face Pain. 49(1). 21–30. 61 indexed citations

10.

Dahlöf, Carl, Elizabeth Loder, Merle L. Diamond, et al.. (2007). The impact of migraine prevention on daily activities: a longitudinal and responder analysis from three topiramate placebo-controlled clinical trials. Health and Quality of Life Outcomes. 5(1). 56–56. 35 indexed citations

11.

Brown, Jeffrey S., Peter J. Neumann, George Papadopoulos, et al.. (2007). Migraine Frequency and Health Utilities: Findings from a Multisite Survey. Value in Health. 11(2). 315–321. 22 indexed citations

12.

Brandes, Jan Lewis, Timothy R. Smith, Merle L. Diamond, & Michael Ames. (2007). Open‐Label, Long‐Term Tolerability of Naratriptan for Short‐Term Prevention of Menstrually Related Migraine. Headache The Journal of Head and Face Pain. 47(6). 886–894. 28 indexed citations

13.

Smith, Timothy R., Harvey J. Blumenthal, Merle L. Diamond, et al.. (2007). Sumatriptan/Naproxen Sodium for Migraine: Efficacy, Health Related Quality of Life, and Satisfaction Outcomes. Headache The Journal of Head and Face Pain. 47(5). 683–692. 30 indexed citations

14.

Diamond, Merle L., et al.. (2006). Optimizing migraine therapy: evidence-based and patient-centered care. Expert Review of Neurotherapeutics. 6(6). 911–919. 15 indexed citations

15.

Cady, Roger, Vincent T. Martin, James U. Adelman, et al.. (2004). Migraine Treatment With Rizatriptan and Non‐Triptan Usual Care Medications: A Pharmacy‐Based Study. Headache The Journal of Head and Face Pain. 44(9). 900–907. 6 indexed citations

16.

Lipton, Richard B., Seymour Diamond, Michael L. Reed, Merle L. Diamond, & Walter F. Stewart. (2001). Migraine Diagnosis and Treatment: Results From the American Migraine Study II. Headache The Journal of Head and Face Pain. 41(7). 638–645. 573 indexed citations breakdown →

17.

Diamond, Seymour, et al.. (2001). Divalproex in the Long‐term Treatment of Chronic Daily Headache. Headache The Journal of Head and Face Pain. 41(3). 271–278. 48 indexed citations

18.

Evans, Randolph W. & Merle L. Diamond. (2000). Is Sumatriptan Use Safe During Pregnancy?. Headache The Journal of Head and Face Pain. 40(10). 856–857. 2 indexed citations

19.

Evans, Randolph W. & Merle L. Diamond. (2000). Is Sumatriptan Use Safe During Pregnancy?. Headache The Journal of Head and Face Pain. 40(10). 856–857. 7 indexed citations

20.

Freitag, Frederick G., Seymour Diamond, & Merle L. Diamond. (1991). A Placebo Controlled Trial of Flunarizine in Migraine Prophylaxis. Cephalalgia. 11(11_suppl). 157–158. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact